A randomized, multicenter study of daylight mediated photodynamic therapy with Metvix cream 160 mg/g in patients with multiple actinic keratoses on the face and scalp.

Trial Profile

A randomized, multicenter study of daylight mediated photodynamic therapy with Metvix cream 160 mg/g in patients with multiple actinic keratoses on the face and scalp.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Nov 2012

At a glance

  • Drugs Methyl aminolevulinate (Primary)
  • Indications Actinic keratosis; Skin cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Apr 2012 Actual end date changed from Jan 2009 to Mar 2009 as reported by European Clinical Trials Database.
    • 17 Mar 2012 Actual end date changed from Mar 2009 to Jan 2009 as reported by European Clinical Trials Database.
    • 17 Mar 2012 Actual initiation date changed from Jun 2008 to Apr 2008 as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top